Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | - CEO | XSHE Exchange | CNE000000BG1 ISIN |
China Country | 7,064 Employees | - Last Dividend | 27 Jul 2018 Last Split | - IPO Date |
Shandong Xinhua Pharmaceutical Company Limited operates as a multifaceted pharmaceutical enterprise within the People's Republic of China and extends its reach globally, including the Americas and Europe. Established in 1943 and headquartered in Zibo, the company commits to the development, manufacturing, and marketing of a vast spectrum of pharmaceutical products. Its subsidiaries play a crucial role in this expansive operation, ensuring the company maintains its reputable position in the pharmaceutical industry. Besides its primary focus on pharmaceuticals, Shandong Xinhua Pharmaceutical Company Limited also diversifies its interests into the real estate sector, showcasing its versatile business model.
Shandong Xinhua Pharmaceutical Company Limited offers an extensive portfolio of products and services across various therapeutic categories:
In addition to its pharmaceutical products, Shandong Xinhua Pharmaceutical Company Limited engages in the real estate sector, showcasing its versatility by venturing into development projects. This diversification strategy highlights the company's dynamic approach to business, aiming to capture growth opportunities beyond its core pharmaceutical endeavors.